1. Introduction {#sec1-molecules-20-19722}
===============

Cardenolides, a chemical class within the cardiac glycosides, have a five-membered lactone group in the β position at C17 \[[@B1-molecules-20-19722]\]. The mechanisms of these compounds are known to inhibit Na^+^/K^+^-ATPase, activate the cation pump, and increase in intracellular calcium concentration through cellular output of Na^+^ and intake of K^+^ \[[@B2-molecules-20-19722]\]. Because of these biological actions, cardenolides have been used in the treatment of heart failure \[[@B3-molecules-20-19722]\]. In addition, many researchers have suggested that cardenolides may inhibit the growth of cancer cells, and have described them as anticancer agents with fewer side effects \[[@B4-molecules-20-19722],[@B5-molecules-20-19722]\].

Cardiac glycosides were isolated from several plant families of Ranunculaceae, Scrophulariazea, Apocynaceae, and Liliaceae, along with pregnane glycosides \[[@B6-molecules-20-19722]\]. In Korea, the *Adonis* family is mainly comprised of three species, *A. amurensis*, *A. pseudoamurensis*, and *A. multiflora* based on RAPD analysis \[[@B7-molecules-20-19722],[@B8-molecules-20-19722]\]. Previous phytochemical studies conducted on the roots of *A. amurensis*, the most well-known *Adonis* species, have identified several cardenolides: corchoroside A, covallatoxin, cymarin, cymarol, digitoxigenin 3-*O*-β-[d]{.smallcaps}-cymaroside, k-strophanthin, and k-strophanthin-β \[[@B9-molecules-20-19722]\]. However, little has been reported concerning the biological and phytochemical properties of *A. multiflora*, except a brief report \[[@B10-molecules-20-19722]\]. We have confirmed the presence of cardenolide spots in the TLC of ethanolic extracts from whole plants of *A. multiflora* based on the UV absorption pattern and the colors produced by spraying with a 10% H~2~SO~4~ solution and heating. Over the course of investigating cardenolides in whole plants of *A. multiflora* Nishikawa & Koki Ito, two new cardenolides **1** and **6** were identified and structurally determined, along with four known ones **2**--**5** ([Figure 1](#molecules-20-19722-f001){ref-type="fig"}). The cardenolides were then evaluated for cytotoxity against six human cancer cell lines (HCT-116, HepG2, HeLa, SK-OV-3, SK-BR-3, and SK-MEL-5).

![Compounds **1**--**6** isolated from the whole plants of *Adonis multiflora*.](molecules-20-19722-g001){#molecules-20-19722-f001}

2. Results and Discussion {#sec2-molecules-20-19722}
=========================

The EtOH extracts were partitioned into CH~2~Cl~2~, EtOAc, BuOH, and H~2~O fractions. Repeated SiO~2~ and ODS column chromatography of the CH~2~Cl~2~ and BuOH fractions resulted in the identification of two new cardenolides, named adonioside A (**1**) and adonioside B (**6**), along with four known cardenolides **2**--**5**. The known compounds were identified as tupichinolide (**2**), oleandrine (**3**), cryptostigmin II (**4**), and cymarin (**5**) on the basis of spectroscopic analysis and the identities were confirmed by comparing their measured spectroscopic data with those reported in the literature \[[@B11-molecules-20-19722],[@B12-molecules-20-19722],[@B13-molecules-20-19722],[@B14-molecules-20-19722]\].

Compound **1** was isolated as a white powder and showed IR absorbance bands representing OH (3384 cm^−1^), CHO (1737 cm^−1^), and C=C (1639 cm^−1^) groups. The molecular weight was determined to be 606 from the molecular ion peak *m/z* 605 \[M − H\]^−^ in the negative FAB-MS spectrum, and a molecular formula of C~32~H~46~O~11~ was determined from the high-resolved molecular ion peak (\[M − H\]^−^, *m*/*z* 605.2971, calc. for C~32~H~45~O~11~, 605.2962) in the negative HR-FAB-MS. The ^1^H-NMR spectrum ([Table 1](#molecules-20-19722-t001){ref-type="table"}) exhibited the characteristics of an α,β-unsaturated-γ-lactone ring, with signals at δ(H) 5.95 (dd, *J* = 1.6, 1.6 Hz, H-22), 4.94 (dd, *J* = 18.4, 1.6 Hz, H-21~a~), and 4.83 (dd, *J* = 18.4, 1.6 Hz, H-21~b~) as well as a tertiary methyl signal at δ(H) 0.92 (s, H-18), a formyl signal at δ(H) 9.92 (s, H-19), two O-bearing CH signals at δ(H) 4.19 (br.s, H-3) and 5.41 (ddd, *J* = 9.6, 8.4, 8.4 Hz, H-16), and an AcO signal at δ(H) 1.95 (s, H-AcO), which suggested the presence of a cardenolide moiety with two oxygenated methines and an AcO group. In addition, a hemiacetal signal at δ(H) 4.50 (dd, *J* = 9.6, 2.4 Hz, H-1′), three O-bearing CH signals at δ(H) 3.31\~3.67 (H-3′\~5′), an O-bearing CH~3~ signal at δ(H) 3.36 (s, H-CH~3~O), a CH~2~ signal at δ(H) 2.05 (m, H-2′~a~) and 1.66 (m, H-2′~b~), and a CH~3~ signal at δ(H) 1.33 (d, *J* = 6.8 Hz, H-6′), indicated that **1** was a cardiac monoglycoside with a β-diginopyranoside.

The ^13^C-NMR spectrum showed 32 C-atoms signals ([Table 1](#molecules-20-19722-t001){ref-type="table"}). The aglycone with α,β-unsaturated-γ-lactone ring signals observed at δ(C) 173.9 (C-23), 167.3 (C-20), 121.5 (C-22), and 75.5 (C-21), a formyl signal at δ(C) 208.1 (C-19), two O-bearing quaternary signals at δ(C) 73.5 (C-5) and 83.9 (C-14), AcO signals at δ(C) 170.4 (C-OAc) and 21.0 (C-OAc), two O-bearing CH signals at δ(C) 74.1 (C-3) and 73.7 (C-16), and a tertiary CH~3~ signal at δ(C) 15.8 (C-18) indicated that the aglycone was a cardenolide with four hydroxyls, one formyl, and one AcO group. The monosaccharide carbon signals, including a hemiacetal signal at δ(C) 98.9 (C-1′), three O-bearing CH signals at δ(C) 77.6 (C-3′), 70.7 (C-5′), 66.9 C-4′), a CH~3~O signal at δ(C) 55.8 (C-CH~3~O), a CH~2~ signal at δ(C) 31.5 (C-2′), and a CH~3~ signal at δ(C) 16.7 (C-6′), allowed us to conclude that the sugar was β-diginopyranose.

Acid hydrolysis of **1** and purification of the hydrolysate using column chromatography resulted in a sugar compound, which was identified to be a diginopyranose by direct comparison between its *R~f~* values on the SiO~2~ TLC (0.47 with CHCl~3~/MeOH 9:1, and 0.19 with CH~2~Cl~2~/EtOH 9:1) and those of an authentic sample. The specific rotation value of the obtained sugar ($\left\lbrack \text{α} \right\rbrack_{D}^{20}$ = +56.8, *c* = 0.11, H~2~O), and the large *J* value of the anomeric signal at δ(H) 4.50 (dd, *J* = 9.6, 2.4 Hz, H-1′) revealed the sugar to be β-[d]{.smallcaps}-diginopyranose. The location of β-[d]{.smallcaps}-diginopyranose, methyl, formyl, hydroxyls, and AcO groups of **1** were determined from the connectivity between the oxygenated methine proton δ(H) 4.50 (1H, d, *J* = 9.6, 2.4 Hz, H-1′) and O-bearing CH carbon δ(C) 74.1 (C-3), tertiary methyl proton δ(H) 0.92 (s, H-18) and quaternary carbon δ(C) 49.8 (C-13), formyl proton δ(H) 9.92 (s, H-19) and quaternary carbon δ(C) 54.3 (C-10), tertiary methyl proton δ(H) 0.92 (s, H-18) and O-bearing quaternary carbon δ(C) 83.9 (C-14) and O-bearing methine proton δ(H) 5.41 (ddd, *J* = 9.6, 8.4, 8.4 Hz, H-16) and AcO carbon δ(C) 170.4 (C-OAc) in the HMBC spectrum, respectively. The location of the lactone group was deduced from the connectivity between the methylene protons H-15 δ(H) 2.59 (dd, *J* = 15.6, 9.6 Hz, H-15), O-bearing methine proton δ(H) 5.41 (ddd, *J* = 9.6, 8.4, 8.4 Hz, H-16) and the methine proton δ(H) 3.15 (d, *J* = 8.4 Hz, H-17) in the COSY spectrum ([Figure 2](#molecules-20-19722-f002){ref-type="fig"}). Taken together, compound **1** was determined to be a 16-β-acetoxystrophanthidin 3-*O*-β-[d]{.smallcaps}-digonopyranoside, a new cardenolide named adonioside A.

Compound **6** was also isolated as a white powder and showed IR absorbance bands of OH (3387 cm^−1^), CHO (1742 cm^−1^), and C=C (1647 cm^−1^) groups. The molecular weight was determined to be 710 due to the pseudomolecular ion peak *m/z* 733 \[M + Na\]^+^ in the positive FAB-MS spectrum, and the molecular formula of C~36~H~54~O~14~ was determined by the high-resolution pseudomolecular ion peak (\[*M* + Na\]^+^, *m*/*z* 733.3511, calc. for C~36~H~54~O~14~Na, 733.3411) in the positive HR-FAB-MS. The ^1^H-NMR spectrum ([Table 1](#molecules-20-19722-t001){ref-type="table"}) displayed a formyl signal at δ(H) 10.33 (s, H-19), an olefin CH signal at δ(H) 6.10 (s, H-22), O-bearing CH~2~ signals at δ(H) 5.25 (d, *J* = 18.4 Hz, H-21~a~) and 4.99 (d, *J* = 18.4 Hz, H-21~b~), O-bearing CH signal at δ(H) 4.64 (br.s, H-3), and a tertiary CH~3~ at δ(H) 0.98 (s, H-18) indicating that **6** has a cardenolide skeleton. Also, two hemiacetal signals at δ(H) 5.07 (d, *J* = 7.6 Hz, H-1′) and 4.69 (br.d, *J* = 9.2 Hz, H-1′′) were observed, and their large *J* values confirmed that the anomer hydroxyls were in β form. Two hexoses were determined to be β-diginopyranosyl-(1→4)-β-diginopyranose through comparisons between ^13^C-NMR data and those reported in previously published literature \[[@B15-molecules-20-19722]\]. Acid hydrolysis of **6** and comparison of the specific rotation values of two isolated sugars \[**6a**: $\left\lbrack \text{α} \right\rbrack_{D}^{20}$ = +55.5 (*c* = 0.12, H~2~O), **6b**: $\left\lbrack \text{α} \right\rbrack_{D}^{20}$ = +49.3 (*c* = 0.12, H~2~O)\] led to the identification of two sugars, [d]{.smallcaps}-diginopyranose ($\left\lbrack \text{α} \right\rbrack_{D}^{20}$ = +59.6) and [d]{.smallcaps}-glucopyranose ($\left\lbrack \text{α} \right\rbrack_{D}^{20}$ = +52.5) \[[@B16-molecules-20-19722],[@B17-molecules-20-19722]\]. The locations of functional groups were determined by gCOSY and gHMBC experiments ([Figure 2](#molecules-20-19722-f002){ref-type="fig"}). Thus, compound **6** was identified as strophanthidin 3-*O*-β-[d]{.smallcaps}-diginopyranosyl-(1→4)-β-[d]{.smallcaps}-glucopyronoside, a new cardenolide named adonioside B.

molecules-20-19722-t001_Table 1

###### 

^1^H- and ^13^C-NMR Data (400 and 100 MHz, resp.) of compounds **1** and **6**.

  Position   1 (CD~3~OD)                        6 (C~5~D~5~N)                                   
  ---------- ---------------------------------- --------------- ------------------------------- -------
             δ(H)                               δ(C)            δ(H)                            δ(C)
  1          2.05 (m)                           23.6            2.52 (m)                        18.6
             1.13 (m)                                           1.83 (m)                        
  2          2.04 (m)                           25.1            2.06 (m)                        25.5
             1.42 (m)                                           1.64 (m)                        
  3          4.19 (br.s)                        74.1            4.64 (br.s)                     74.5
  4          1.94 (m)                           35.2            2.27 (m)                        37.0
             1.62 (m)                                           1.81 (m)                        
  5                                             73.5                                            73.8
  6          1.93 (m)                           35.9            2.17 (m)                        36.0
             1.57 (m)                                           1.76 (m)                        
  7          1.51 (m)                           21.4            1.52 (m)                        24.8
             1.43 (m)                                           1.32 (m)                        
  8          1.96 (m)                           41.4            2.26 (m)                        41.9
  9          1.41 (m)                           39.0            1.64 (m)                        39.5
  10                                            54.3                                            55.2
  11         2.26 (br.dd, *J* = 14.8, 3.6)      18.1            2.43 (m)                        22.6
             1.65 (m)                                           1.40 (m)                        
  12         1.55 (m)                           39.1            1.39 (m)                        39.6
             1.23 (m)                                           1.28 (m)                        
  13                                            49.8                                            49.8
  14                                            83.9                                            84.4
  15         2.59 (dd, *J* = 15.6, 9.6)         40.0            2.02 (m)                        32.2
             1.74 (m)                                           1.79 (m)                        
  16         5.41(ddd, *J* = 9.6, 5.8, 2.8)     73.7            2.07 (m)                        27.2
                                                                1.96 (m)                        
  17         3.15 (d, 8.4)                      55.6            2.76 (m)                        51.1
  18         0.92 (s)                           15.8            0.98 (s)                        16.0
  19         9.92 (s)                           208.1           10.33 (s)                       208.4
  20                                            167.3                                           175.6
  21         4.94 (dd, *J* = 18.4, 1.6)         75.5            5.25 (d, *J* = 18.4)            73.7
             4.83 (dd, *J* = 18.4, 1.6)                         4.99 (d, *J* = 18.4)            
  22         5.95 (dd, *J* = 1.6, 1.6)          121.5           6.10 (s)                        117.8
  23                                            173.9                                           174.4
  AcO        1.93 (s)                           170.4, 21.0                                     
             Dgn ^(a)^                                          Dgn                             D-Dig
  1′         4.50 (dd, *J* = 9.6, 2.4)          98.9            5.07 (br.d, *J* = 9.6)          99.5
  2′         2.05 (m)                           31.5            2.15 (m)                        32.6
             1.66 (m)                                                                           
  3′         3.31 (ddd, *J* = 12.8, 5.2, 2.0)   77.6            3.34 (br.dd, *J* = 12.0, 3.6)   79.7
  4′         3.67 (br.s)                        66.9            4.10 (br.s)                     73.9
  5′         3.43 (br.q, *J* = 6.8)             70.7            3.48 (br.q, *J* = 6.4)          71.1
  6′         1.33 (d, *J* = 6.8)                16.7            1.49 (d, *J* = 6.4)             17.8
  MeO        3.36 (s)                           55.8            3.28 (s)                        56.1
                                                                Glc ^(b)^                       
  1′′                                                           4.69 (d, *J* = 7.6)             104.9
  2′′                                                           3.91 (dd, *J* = 8.8, 7.6)       75.9
  3′′                                                           4.16 (dd, *J* = 8.8, 8.8)       78.5
  4′′                                                           4.10 (dd, *J* = 8.8, 8.8)       71.9
  5′′                                                           3.89 (m)                        78.3
  6′′                                                           4.51 (dd, *J* = 11.2, 1.6)      63.1
                                                                4.30 (dd, *J* = 11.2, 6.0)      

^(a)^ β-[d]{.smallcaps}-diginopyranose; ^(b)^ β-[d]{.smallcaps}-glucopyranose δ in ppm, *J* in Hz. Atom numbering as indicated in [Figure 1](#molecules-20-19722-f001){ref-type="fig"}.

![^1^H-^1^H-COSY (−) and gHMBC (H→C) key correlations of compounds **1** and **6**.](molecules-20-19722-g002){#molecules-20-19722-f002}

All of the isolated cardenolides from *A. multiflora* were evaluated for cytotoxicity against six human cancer cell lines (HCT-116, HepG2, HeLa, SK-OV-3, SK-BR-3, and SK-MEL-5). As shown in [Table 2](#molecules-20-19722-t002){ref-type="table"}, compounds **1**, **2**, **5**, and **6** showed significant inhibition activity against HCT-116, SK-OV-3, and SK-MEL-5 cell lines with IC~50~ values ranging from 0.06 ± 0.02 to 7.44 ± 1.98 µM. Compound **3** showed cytotoxic effects against the HeLa cell line with an IC~50~ value of 8.85 ± 0.39 µM. Compound **4** showed cytotoxicity against the SK-MEL-5 cell line with an IC~50~ value of 1.99 ± 0.28 µM.

molecules-20-19722-t002_Table 2

###### 

Cytotoxic activity of compounds **1**--**6** against human cancer cell lines (IC~50~ \[µM\] ^(a)^).

  Compound      Cell lines (IC~50~) μM                                                               
  ------------- ------------------------ -------------- -------------- -------------- -------------- --------------
  **1**         4.10 ± 0.38              14.65 ± 0.47   38.54 ± 1.08   2.34 ± 0.10    3.40 ± 0.67    38.35 ± 1.49
  **2**         0.41 ± 0.13              17.99 ± 0.61   9.38 ± 0.15    0.06 ± 0.02    0.28 ± 0.06    2.58 ± 0.23
  **3**         34.99 ± 1.39             30.12 ± 1.60   8.85 ± 0.39    25.38 ± 0.51   34.17 ± 1.78   80.38 ± 1.13
  **4**         24.32 ± 1.26             26.61 ± 0.70   23.27 ± 1.73   41.02 ± 0.13   1.99 ± 0.28    23.94 ± 1.47
  **5**         1.64 ± 0.13              2.87 ± 0.77    25.38 ± 0.15   0.76 ± 0.15    0.73 ± 0.14    5.10 ± 0.87
  **6**         7.44 ± 1.98              13.71 ± 0.75   44.71 ± 0.89   4.63 ± 0.47    4.98 ± 0.56    21.30 ± 1.50
  Doxorubicin   9.20 ±0.90               27.30 ± 0.50   3.20 ± 0.30    0.58 ± 0.08    4.80 ± 0.23    0.71 ± 0.05

^(a)^ All data were represented as mean ± SD of triplicate experiments.

3. Experimental Section {#sec3-molecules-20-19722}
=======================

3.1. General {#sec3dot1-molecules-20-19722}
------------

Column chromatography (CC): SiO~2~ (Kieselgel 60, Merck, Darmastdt, Germany) and ODS (LiChroprep RP-18, Merck) resins. TLC: Kieselgel 60 F~254~ and RP-18 F~254S~ (Merck) plates; visualization with UV lamp Spectroline Model ENF-240 C/F (Spectronics Corporation, Westbury, NY, USA) and spraying 10% H~2~SO~4~ soln. in MeOH and heating. Optical rotations: JASCO P-1010 digital polarimeter (Jasco, Tokyo, Japan). IR spectra: Perkin Elmer Spectrum One FT-IR spectrometer (Perkin Elmer, Beaconsfield, UK). FAB-MS: JEOL JMSAX-700 mass spectrometer (Jeol, Tokyo, Japan). NMR spectra: Varian Unity Inova AS-400 FT-NMR spectrometer (Varian, Palo Alto, CA, USA).

3.2. Plant Materials {#sec3dot2-molecules-20-19722}
--------------------

*A. multiflora* Nishikawa & Koki Ito was supplied from the BMI Corporation (Uiwang, Korea) in January 2014, and was identified by *professor Dae-Keun Kim*, College of Pharmacy, Woosuk University, Jeonju, Korea. A voucher specimen (KHU2014-0117) has been reserved at the Laboratory of Natural Products Chemistry, Kyung Hee University, Yongin, Korea.

3.3. Extraction and Isolation {#sec3dot3-molecules-20-19722}
-----------------------------

The whole plants of *A. multiflora* (1.5 kg) were extracted with 70% aqueous EtOH (30 L) at room temperature for 24 h. The concentrated EtOH extracts (106 g) were suspended in H~2~O (3 L) and then successively extracted with CH~2~Cl~2~ (AAC; 2.6 g), AcOEt (AAE; 0.7 g), BuOH (AAB; 12 g), and H~2~O (AAW; 89.2 g). The AAC (2.6 g) was subjected to CC \[SiO~2~ (φ 4 × 11 cm); CH~2~Cl~2~/MeOH 18:1, 15:1, 7:1, 1.6 L of each\] yielding 16 fractions, AAC-1--AAC-16. Fr. AAC-3 (200 mg, elution volume/total volume (V~e~/V~t~) 0.03--0.06) was subjected to CC \[ODS (φ 3 × 7 cm); MeOH/H~2~O 3:1, 2.4 L\], yielding 14 fractions, AAC-3-1--AAC-3-14. Fr. AAC-3-1 (52 mg, V~e~/V~t~ 0.00--0.09) was subjected to CC \[SiO~2~ (φ 1.5 × 15 cm); Hexane/AcOEt 1:12, 0.5 L\], yielding six fractions, AAC-3-1-1--AAC-3-1-6 along with a purified compound **1** \[AAC-3-1-2; 12 mg; V~e~/V~t~ 0.46--0.52; TLC (ODS F~254S~; MeOH/H~2~O 5:2): *R~f~* 0.60\]. Fr. AAC-4 (130 mg, V~e~/V~t~ 0.06--0.08) was subjected to CC \[ODS (φ 3 × 7 cm); MeOH/H~2~O 4:5, 1.3 L\], yielding 14 fractions, AAC-4-1--AAC-4-12 along with a purified compound **5** \[AAC-4-9; 40 mg; V~e~/V~t~ 0.63--0.81; TLC (ODS F~254S~; MeOH/H~2~O 3:2): *R~f~* 0.45\]. Fr. AAC-7 (200 mg, V~e~/V~t~ 0.17--0.22) was subjected to CC \[ODS (φ 3 × 5 cm); MeOH/H~2~O 3:1, 1.6 l\], yielding nine fractions, AAC-7-1--AAC-7-9 along with a purified compound **2** \[AAC-7-2; 12 mg; V~e~/V~t~ 0.05--0.07; TLC (ODS F~254S~; MeOH/H~2~O 4:1): *R~f~* 0.45\]. Fr. AAC-14 (121 mg, V~e~/V~t~ 0.62--0.66) was subjected to CC \[ODS (φ 3 × 6 cm); MeOH/H~2~O 1:2, 2.7 L\], yielding 11 fractions, AAC-14-1--AAC-14-11 along with a purified compound **3** \[AAC-14-2; 8 mg; V~e~/V~t~ 0.04--0.19; TLC (ODS F~254S~; MeOH/H~2~O 2:1): *R~f~* 0.60\], and compound **4** \[AAC-14-6; 12 mg; V~e~/V~t~ 0.53--0.69; TLC (ODS F~254S~; MeOH/H~2~O 2:1): R~f~ 0.50\]. The AAB (12 g) was subjected to CC \[SiO~2~ (φ 7.5 × 16 cm); CH~2~Cl~2~/MeOH/H~2~O 13:3:1, 9:3:1, 7:3:1, 65:35:10, 7 L of each\] yielding 15 fractions, AAB-1--AAC-15. Fr. AAC-5 (300 mg, V~e~/V~t~ 0.06--0.10) was subjected to CC \[ODS (φ 2.5 × 5 cm); MeOH/H~2~O 2:3, 1 L\], yielding nine fractions, AAB-5-1--AAC-5-9 along with a purified compound **6** \[AAB-5-7; 28 mg; V~e~/V~t~ 0.38--0.71; TLC (ODS F~254S~; MeOH/H~2~O 6:5): *R~f~* 0.30\].

3.4. Spectroscopic Data {#sec3dot4-molecules-20-19722}
-----------------------

*Adonioside A* (**1**)*.* White powder. $$\left\lbrack \text{α} \right\rbrack_{D}^{20}$$ = +23.9 (*c* = 0.5, MeOH). IR (CaF~2~): 3384, 2923, 1737, 1639, 1167, 1077 cm^−1^. ^1^H- and ^13^C-NMR: [Table 1](#molecules-20-19722-t001){ref-type="table"}. negative HR-FAB-MS: 605.2971 (\[M − H\]^−^, C~32~H~45~O~11~; calc. 605.2962).

*Adonioside B* (**6**). White powder. $$\left\lbrack \text{α} \right\rbrack_{D}^{20}$$ = −94.4 (*c* = 0.7, pyridine). IR (CaF~2~): 3387, 2933, 1742, 1647, 1178, 1097 cm^−1^. ^1^H- and ^13^C-NMR: [Table 1](#molecules-20-19722-t001){ref-type="table"}*.* positive HR-FAB-MS: 733.3511 (\[M + Na\]^+^, C~36~H~54~O~14~Na; calc. 733.3414).

3.5. Acid Hydrolysis of ***1*** and ***6*** {#sec3dot5-molecules-20-19722}
-------------------------------------------

Compound **1** (10 mg) and compound **6** (20 mg) were refluxed in 2 N HCl (0.3 mL) at 80 °C for 5 h, followed by neutralization with Ag~2~CO~3~ in excess and filtered through filter paper. The filtrate of **1** was subjected to CC \[SiO~2~ (φ 1 × 10 cm); CHCl~3~/MeOH 12:1\] to give fractions of sugar (**1a**) and aglycone, and that of **6** was subjected to CC \[SiO~2~ (φ 1 × 10 cm); CHCl~3~/MeOH 12:1, 1:1\] to give fractions of sugars **6a**, and **6b** and aglycone. The monosaccharides **1a**, **6a**, and **6b** in each sugar fraction were identified to be diginose, diginose, and glucose, respectively, by TLC comparison with authentic sugars. The *R~f~* values of diginose was 0.37 with CHCl~3~/MeOH 9:1 and 0.47 with CH~2~Cl~2~/EtOH 9:1, and that of glucose was 0.30 with CHCl~3~/MeOH/ H~2~O 7:3:0.5 \[[@B18-molecules-20-19722],[@B19-molecules-20-19722]\].

3.6. Determination of Absolute Configuration of ***1a***, ***6a***, and ***6b*** {#sec3dot6-molecules-20-19722}
--------------------------------------------------------------------------------

The sugar fractions, **1a** (1 mg), **6a** (1.2 mg), and **6b** (1.2 mg), were measured for optical rotation values and compared with those reported in literature. Diginose, **1a** and **6a,** were determined to be [d]{.smallcaps}-form \[**1a**: $\left\lbrack \text{α} \right\rbrack_{D}^{20}$ = +56.8 (*c* = 0.11, H~2~O), **6a**: $\left\lbrack \text{α} \right\rbrack_{D}^{20}$ = +55.5 (*c* = 0.12, H~2~O); [d]{.smallcaps}-diginose: $\left\lbrack \text{α} \right\rbrack_{D}^{20}$ = +59.6\]. Glucose **6b** was determined to be [d]{.smallcaps}-form \[**6b**: ($\left\lbrack \text{α} \right\rbrack_{D}^{20}$ = +49.3 (*c* = 0.12, H~2~O); [d]{.smallcaps}-glucose: $\left\lbrack \text{α} \right\rbrack_{D}^{20}$ = +52.5\] \[[@B16-molecules-20-19722],[@B17-molecules-20-19722]\].

3.7. Cell Culture {#sec3dot7-molecules-20-19722}
-----------------

Human hepatoma (HepG2), human cervix adenocarcinoma (HeLa), human ovarian adenocarcinoma (SK-OV-3), human breast adenocarcinoma (SK-BR-3), human colon carcinoma (HCT-116), human melanoma (SK-MEL-5) cells were obtained from the Korean Cell Line Bank (KCLB, Seoul, Korea). HepG2 and HeLa cells were maintained in Dulbecco's modified Eagle's medium (DMEM) supplemented with 10% (*v*/*v*) heat-inactivated fetal bovine serum (FBS) and 1% (*v*/*v*) penicillin-streptomycin in a humidified incubator with 5% CO~2~ at 37 °C. SK-OV-3, SK-BR-3, HCT-116, and SK-MEL-5 cells were maintained in RPMI1640 medium containing 10% (*v*/*v*) heat-inactivated FBS and 1% (*v*/*v*) penicillin-streptomycin in a humidified incubator with 5% CO~2~ at 37 °C. All cell culture media and reagents were purchased form Thermo Scientific Hyclone (Logan, UT, USA).

3.8. Cytotoxicity Assay {#sec3dot8-molecules-20-19722}
-----------------------

The cytotoxicity of cardenolides from *A. multiflora* was measured by a MTT colorimetric assay. Compounds were dissolved with dimethylsulfoxide (DMSO). The cells were seeded onto 96-well microplates at a density of 1 x 10^4^ cells per well in 100 μL of medium each. After incubation at 37 °C in a humidified incubator for 24 h, the cells were treated with various concentrations (1, 0.1, 0.5, 1, 5, 10, 50, 100 μM) of each compound in serum-free medium for 24 h. After incubation, 50 μL of MTT (5 mg/mL in PBS) was added to each well of the plate. The cells were incubated at 37 °C for 2 h. After removal from the medium, the cells were treated with 100 μL DMSO for 5 min and optical density measured using a microplate reader (BIO-TEK Inc., Winooski, VT, USA) at 550 nm. Cell viability was calculated as a percentage of viable cells in the compound-treated group *vs.* the control group by the following equation: Cell viability (%) = \[OD (Compound) − OD (Blank)/OD (Control)-OD (Blank)\] × 100.

3.9. Statistical Analysis {#sec3dot9-molecules-20-19722}
-------------------------

All experiments were performed with triplicate samples and repeated at least three times. The data are presented as means ± SD and statistical comparisons between groups were performed using 1-way ANOVA followed by Student's *t*-test.

4. Conclusions {#sec4-molecules-20-19722}
==============

Two new and four known cardiac glycosides were isolated from the whole plants of *Adonis multiflora* Nishikawa & Koki Ito using open column chromatography and were identified based on spectroscopic data analysis, including NMR and FAB-MS. For the determination of absolute configuration, acid hydrolysis was performed. As a result, compound **1** and **6** were determined to be a 16-β-acetoxystrophanthidin 3-*O*-β-[d]{.smallcaps}-digonopyranoside, named adonioside A (**1**) and strophanthidin 3-*O*-β-[d]{.smallcaps}-diginopyranosyl-(1→4)-β-[d]{.smallcaps}-glucopyronoside, named adonioside B (**6**). In addition, the two new compounds **1** and **6** together with the two known compounds **2** and **5** showed significant cytotoxicity against six human cancer cell lines, HCT-116, HepG2, HeLa, SK-OV-3, and SK-MEL-5, and SK-BR-3, but we couldn't establish a consistent structure-activity relationship. Consequently, these four compounds **1**, **2**, **5** and **6** merit futher *in vivo* study and on normal cell lines for bioactive selectivity. These findings suggest that *A. multiflora* may have potential be a useful therapeutic natural source for cancer prevention.
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